Kurt Stern
Impact in
-
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 4
-
- Quinazolinone synthesis and applications 2
- Synthesis and Characterization of Heterocyclic Compounds 2
- Co-authors
- Gary E. Zurenko (3 shared papers)Robert D. Birkenmeyer (2 shared papers)Stephen Kroll (2 shared papers)Lionel E. Rhuland (4 shared papers)Jack E. Gray (4 shared papers)W. Morozowich (1 shared paper)Harold A. Karnes (1 shared paper)C. J. Lewis (1 shared paper)
- Journals
- JAMA (6 papers)American Journal of Clinical Pathology (5 papers)Toxicology and Applied Pharmacology (2 papers)Journal of Medicinal Chemistry (2 papers)Oncology (2 papers)
- Partner nations
- United StatesIsrael
In The Last Decade
Kurt Stern
26 papers receiving 231 citations
Peers
Comparison fields: 5 of 85
- Molecular Medicine 13
- Transplantation 6
- Pharmacology 33
- Microbiology 11
- Chemical Health and Safety 1
Countries citing papers authored by Kurt Stern
This map shows the geographic impact of Kurt Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Stern more than expected).
Fields of papers citing papers by Kurt Stern
This network shows the impact of papers produced by Kurt Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Stern. The network helps show where Kurt Stern may publish in the future.
Co-authors
The 16 scholars most cited alongside Kurt Stern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 45 | |
| 2 | 1954 | 38 | |
| 3 | 1967 | 34 | |
| 4 | 1969 | 16 | |
| 5 | 1965 | 16 | |
| 6 | 1970 | 14 | |
| 7 | 1964 | 13 | |
| 8 | 1956 | 12 | |
| 9 | 1984 | 12 | |
| 10 | 1974 | 10 | |
| 11 | 1963 | 9 | |
| 12 | 1957 | 8 | |
| 13 | 1971 | 6 | |
| 14 | 1963 | 6 | |
| 15 | 1953 | 5 | |
| 16 | In vivo Studies in the Tuberculous Mouse. | 1957 | 4 |
| 17 | 1958 | 4 | |
| 18 | 1957 | 4 | |
| 19 | 1978 | 4 | |
| 20 | 1971 | 3 |
About Kurt Stern
Kurt Stern is a scholar working on Infectious Diseases, Organic Chemistry, Surgery, Molecular Biology and Pharmacology, having authored 27 papers that have together received 275 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (4 papers), Quinazolinone synthesis and applications (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Hematological disorders and diagnostics (2 papers), Chemical Synthesis and Analysis (2 papers), Infectious Diseases and Tuberculosis (2 papers), Ginger and Zingiberaceae research (2 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Molecular Medicine (13 citations), Transplantation (6 citations), Pharmacology (33 citations), Microbiology (11 citations) and Chemical Health and Safety (1 citation). Kurt Stern has collaborated with scholars based in United States and Israel. Frequent co-authors include Gary E. Zurenko, Robert D. Birkenmeyer, Stephen Kroll, Lionel E. Rhuland, Jack E. Gray, W. Morozowich, Harold A. Karnes, C. J. Lewis, Rachel Schreiber and Forrest A. MacKellar. Their work appears in journals such as JAMA, American Journal of Clinical Pathology, Toxicology and Applied Pharmacology, Journal of Medicinal Chemistry and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.